MS vs ORKA · P/E 20, $344.27B cap vs $4.27B cap
Morgan Stanley (MS) versus Oruka Therapeutics, Inc. (ORKA) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
MS does not have a complete income-statement cache yet.
Latest reported ORKA revenue for 2024-06-30 was $0. Net income was -$22.2M. ORKA currently screens at market cap $4.27B.
MS currently screens at market cap $344.27B and trailing P/E 19.8. ORKA currently screens at market cap $4.27B.
Not investment advice. Open the MS and ORKA stock pages for the full models.
Not investment advice.